Table 1.
Treatment | N | P28 | P35 | P42 | P49 | |
---|---|---|---|---|---|---|
SAL | 28 | 104.9 ± 4.3 | 169.2 ± 4.3 | 231.6 ± 4.3 | 287.2 ± 4.3 | |
ER 0.40-0.50 | 6 | 73.5 ± 9.2** | 106.0 ± 9.2*** | 130.2 ± 9.2*** | 148.5 ± 9.2*** | |
ER 0.51-0.60 | 9 | 79.2 ± 7.5** | 113.0 ± 7.5*** | 137.7 ± 7.5*** | 156.4 ± 7.5*** | |
ER 0.61-0.70 | 8 | 78.3 ± 8.0** | 109.3 ± 8.0*** | 129.2 ± 8.0*** | 143.9 ± 8.0*** | |
ER 0.71-0.82 | 5 | 80.6± 10.1* | 112.1 ± 10.1*** | 142.8 ± 10.1*** | 162.0 ± 10.1*** |
p < 0.05
p < 0.01
p < 0.001 versus SAL at the same age.